Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC Transplantation for Refractory SLE
NCT01741857Phase 2Unknown
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of human umbilical cord mesenchymal stem cells in systemic lupus erythematosus (SLE), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: British Isles Lupus Assessment Group score at 12 months. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01741857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01741857.